GlassScriptPhysician profile
Nathan Papadeas
NPI 1255734760
$2,342.72
in general payments reported to CMS, 2019-2025
26 companies · $38.74 in 2025
The $38.74 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $908 · 2024: $1,396 · 2025: $38.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,258 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,257.73 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $328.43 | 2023-2024 | |
| Abbvie INC. | $311.24 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $308.75 | 2023-2024 | Prolaris |
| Ferring Pharmaceuticals INC. | $196.01 | 2024 | Adstiladrin |
| Endo USA, INC. | $158.27 | 2024 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $138.20 | 2023-2024 | Pylarify |
| Antares Pharma, INC. | $137.85 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $134.10 | 2024 | |
| Urogen Pharma, INC. | $101.23 | 2023-2024 | Jelmyto |
| Halozyme INC | $75.18 | 2023 | |
| Dendreon Pharmaceuticals LLC | $65.33 | 2024 | Provenge |
| Tolmar, INC. | $43.82 | 2024 | |
| Endo Pharmaceuticals INC. | $36.43 | 2024 | Aveed, Xiaflex |
| Sun Pharmaceutical Industries INC. | $33.82 | 2025 | |
| 180 Medical, INC. | $32.69 | 2023-2024 | Gentlecath, Cure Ultra Catheter |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $26.91 | 2024 | |
| Laborie Medical Technologies Corp. | $25.78 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $23.85 | 2024 | Urolift |
| Sumitomo Pharma America, INC. | $23.76 | 2024 | Gemtesa |
| Janssen Biotech, INC. | $22.48 | 2024 | Erleada |
| Olympus America INC. | $21.90 | 2023 | Itind System |
| Merck Sharp & Dohme LLC | $20.61 | 2024 | |
| Tempus Ai, INC | $19.81 | 2024 | |
| Blue Earth Diagnostics | $19.45 | 2024 | |
| Baxter Healthcare | $18.47 | 2023 | Tisseel |
| Innovation Technologies INC | $18.35 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Papadeas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.